Company intelligence / Profile preview

Amplify

West Jefferson, Ohio, United Statesamplify.com ↗

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

AmplifyBio was a preclinical CRO and CDMO specializing in advanced modalities such as cell, gene, and mRNA therapies. The company offered discovery, optimization, characterization, safety/efficacy/toxicology studies, and manufacturing enablement. It ceased operations in April 2025 due to challenging market conditions for early-stage biotech development.

Therapeutic areas: Other
Modalities: Cell therapyGene therapymRNA-based drugsSmall molecule
Industry: Contract Research Organization

Partnerships

Silo Pharma (pharmacokinetic/tolerability study for chronic pain candidate)Xcell Biosciences (manufacturing process improvement for engineered T-cell receptor therapies targeting solid tumors)RNAV8 Bio (supporting mRNA therapeutic developers from sequence design to GMP manufacture)

Beyond the preview

Go deeper on Amplify.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amplify.

Explore the full profile